Deticene Vial 100 Mg
Deticene Vial 100 Mg represents a significant milestone in cancer therapy, offering a multifaceted approach to combatting various malignancies. Its precise mechanisms may still hold some mysteries, but its unwavering commitment to healing and hope shines brightly. For individuals embarking on the path of recovery, Deticene stands as a testament to the power of science and innovation in the quest to conquer cancer.
|Generic Name (Ingredient)||
Dakarbazin 100 Mg
Assuming your emergency circumstances for this product, visit Urgent Quotation page. Besides, for any pharmaceutical questions, please ask us in the comments section.
Deticene emerges as a formidable non-cell cycle specific antineoplastic agent, representing a beacon of hope in the realm of cancer therapeutics. Although the precise mechanism of its cytotoxic effects remains a subject of ongoing investigation, three plausible mechanisms have been postulated:
|Inhibition of DNA synthesis as a purine analog||Acts as a purine analog, hindering DNA synthesis|
|Alkylating agent||Functions as an alkylating agent, impacting cellular function|
|Interaction with sulfhydryl groups||Inhibits bacterial cell growth by interacting with sulfhydryl groups|
Deticene Active Ingredient
At the heart of Deticene lies the active ingredient dacarbazine, a synthetic analog of the naturally occurring purine precursor 5-amino-1H-imidazole-4-carboxamide (AIC).
Upon intravenous administration, dacarbazine demonstrates a volume of distribution that surpasses total body water content, hinting at potential localization within specific body tissues, most likely the liver. Its departure from the plasma occurs in two phases, with an initial half-life of 19 minutes and a terminal half-life of 5 hours. In patients grappling with renal and hepatic dysfunctions, these half-lives extend to 55 minutes and 7.2 hours, respectively. Notably, approximately 40% of the injected dose is excreted unchanged in the urine within 6 hours, primarily through renal tubular secretion rather than glomerular filtration. Importantly, at therapeutic concentrations, dacarbazine exhibits minimal binding to human plasma proteins.
Deticene assumes a pivotal role in the therapeutic landscape, primarily serving as a treatment modality for metastatic malignant melanoma. Furthermore, it offers a ray of hope for individuals battling Hodgkin’s disease, particularly when integrated as a second-line therapy in conjunction with other efficacious agents. The extensive reach of Deticene extends to various other conditions, including:
- Advanced Soft Tissue Sarcoma
- Advanced Medullary thyroid cancer
- Advanced Pancreatic neuroendocrine tumor
The recommended dosages for Deticene hinge on the specific condition being addressed:
- Malignant Melanoma: A dosage of 2 to 4.5 mg/kg/day for 10 days is typically advised, with the option of repeating treatment at 4-week intervals. Alternatively, an alternate recommended dosage of 250 mg/m²/day IV for 5 days, with the possibility of repeating treatment every 3 weeks.
- Hodgkin’s Disease: In the context of Hodgkin’s disease, a recommended dosage of 150 mg is typically employed.
Deticene emerges as a therapeutic powerhouse, offering multifaceted benefits across a spectrum of conditions. Its primary role in the treatment of metastatic malignant melanoma signifies a beacon of hope for patients. Furthermore, its contribution to Hodgkin’s disease management as a second-line therapy, when paired with other effective agents, underscores its versatility. The far-reaching scope of Deticene extends its healing touch to a diverse array of medical conditions, offering renewed hope and respite.
Deticene is administered intravenously, with the dosage and treatment schedule tailored to the specific ailment under consideration, as well as the overall health status of the patient.
Deticene bears the hallmark of quality, being manufactured by Sanofi-aventis, a renowned name in the pharmaceutical industry.
Onset of Action
It is crucial to recognize that the onset of action for Deticene is contingent upon the condition being treated. Unlike antibiotics or pain relievers, antineoplastic agents like Deticene do not exert an immediate effect. Instead, their therapeutic benefits manifest over extended periods, underscoring the importance of patience and adherence to treatment protocols.
Use the form below to report an error
Please answer the questions as thoroughly and accurately as possible. Your answers will help us better understand what kind of mistakes happen, why and where they happen, and in the end the purpose is to build a better archive to guide researchers and professionals around the world.
The information on this page is not intended to be a substitute for professional medical advice, diagnosis, or treatment. always seek the advice for your physician or another qualified health provider with any questions you may have regarding a medical condition. Always remember to
- Ask your own doctor for medical advice.
- Names, brands, and dosage may differ between countries.
- When not feeling well, or experiencing side effects always contact your own doctor.
The truth is that when we’re sick, or worried about getting sick, the internet won’t help.
According to Wikipedia, cyberchondria is a mental disorder consisting in the desire to independently make a diagnosis based on the symptoms of diseases described on Internet sites.
Why you can't look for symptoms on the Internet
If diagnoses could be made simply from a textbook or an article on a website, we would all be doctors and treat ourselves. Nothing can replace the experience and knowledge of specially trained people. As in any field, in medicine there are unscrupulous specialists, differences of opinion, inaccurate diagnoses and incorrect test results.